Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

27.05 +0.44 (+1.65%)

Official Closing Price Updated: 7:00 PM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

99 100 Next >

Pfizer Just Reminded Investors Why You Should Never Count Its Stock Out ↗

September 30, 2025

The company recently announced an acquisition that will bolster its growth prospects in the GLP-1 obesity market.

Via The Motley Fool

Dollar Dips as Government Shutdown Looms: A Volatile Start to Q4 2025

September 29, 2025

The US dollar experienced a notable weakening against major global currencies today, September 29, 2025, marking a significant shift after a period of sustained strength. This decline is largely...

Via MarketMinute

Global Markets Brace for Impact as US Government Shutdown Looms

September 29, 2025

Washington D.C. – Global financial markets are once again gripped by uncertainty as a potential United States government shutdown looms, threatening to disrupt critical economic data releases and send...

Via MarketMinute

Topics Bonds Economy Workforce

These S&P500 stocks are the most active in today's session ↗

September 29, 2025

Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Premier, Inc. (Nasdaq – PINC), Metsera, Inc. (Nasdaq – MTSR), Anywhere Real Estate Inc. (NYSE – HOUS), The ODP Corporation (Nasdaq – ODP)

September 29, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

The U.S. pharmaceutical industry is at the center of a policy maelstrom.

Via Benzinga

Topics ETFs

Dow Futures Defy Shutdown Fears: A Deep Dive into Market Resilience

September 29, 2025

As the U.S. government teeters on the brink of another shutdown, a seemingly counter-intuitive phenomenon is gripping financial markets: Dow futures are not only holding steady but are showing signs of...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Digital Pharma Advances 2026: AI and Patient-Centric Strategies Transform Pharma Marketing

September 29, 2025

Via PRLog

Topics Artificial Intelligence

Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus ↗

September 29, 2025

The takeover candidate is working on a bispecific antibody, capable of simultaneously blocking two drivers of cancer.

Via Investor's Business Daily

Topics Government

U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears

September 29, 2025

As the clock ticks towards the September 30, 2025, funding deadline, the United States federal government finds itself perilously close to another shutdown. Congressional leaders remain deadlocked on a...

Via MarketMinute

Topics Bonds Economy Government

3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income ↗

September 29, 2025

Right now, these dividend payers are top options for folks who like to set it and forget it.

Via The Motley Fool

Topics Artificial Intelligence Economy

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗

September 29, 2025

President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.

Via Benzinga

Topics Government World Trade

Inside MrBeast's $5 Billion Generosity Machine — and the Hidden Costs Behind It ↗

September 28, 2025

Internet sensation Jimmy Donaldson, better known as MrBeast, has successfully established an entertainment empire valued at over $5 billion.

Via Benzinga

Why Pfizer's Post-COVID Future Looks Brighter Than Ever ↗

September 28, 2025

A robust pipeline of experimental and recently launched drugs could make the next several years exciting ones to be a Pfizer shareholder.

Via The Motley Fool

BridgeBio, Up 80% This Year, Just Unveiled Promising News For Its Pfizer Rival ↗

September 28, 2025

The company ran an exploratory analysis of its drug, Attruby, in patients with cardiomyopathy due to TTR amyloidosis.

Via Investor's Business Daily

Down 55%, Should You Buy the Dip on Pfizer? ↗

September 28, 2025

Pfizer is facing a patent cliff and has a high payout ratio, but it is taking steps to get back on track.

Via The Motley Fool

Topics Intellectual Property

5 Dividend Powerhouses to Buy and Never Sell ↗

September 28, 2025

These blue-chip giants have paid shareholders through wars, recessions, and pandemics.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers

September 27, 2025

In a hypothetical scenario playing out just last week, leading up to September 27, 2025, Johnson & Johnson (NYSE: JNJ) experienced a significant stock rally, capturing the attention of investors and...

Via MarketMinute

Topics Economy Intellectual Property

Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market

September 27, 2025

Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising...

Via MarketMinute

Topics Economy Intellectual Property

US Government Braces for Unprecedented Shutdown: Economic Fallout Looms as Deadline Nears

September 27, 2025

As the clock ticks towards midnight on September 30, 2025, the United States government stands on the precipice of a highly imminent and seemingly unavoidable shutdown. With just days left until the...

Via MarketMinute

Topics Economy Government Workforce

Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet? ↗

September 27, 2025

The company continues to improve its pipeline.

Via The Motley Fool

3 Magnificent Stocks Under $100 to Buy Right Now ↗

September 27, 2025

You won't need a huge amount of cash to invest in these great pharma stocks.

Via The Motley Fool

Pfizer is Locking in New Growth Through a New Acquisition ↗

September 26, 2025

Pfizer is undergoing a new acquisition, exposing it to the weight loss market and additional revenue growth potential, which isn't priced in yet.

Via MarketBeat

Topics Artificial Intelligence

Pfizer Faces Court Over Depo-Provera Brain Tumor Claims ↗

September 26, 2025

Pfizer Inc.

Via Benzinga

Trump's 100% Drug Tariffs 'A Meaningful Commercial Hit' For Americans, But 'Loopholes' Could Blunt Impact, Says Analyst ↗

September 26, 2025

President Donald Trump‘s proposed 100% tariffs on pharmaceuticals could have a smaller impact than initially expected, thanks to certain loopholes. However, the pharmaceutical industry, particularly...

Via Benzinga

Topics Government World Trade

Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock? ↗

September 26, 2025

The pharmaceutical giant is again plunging headfirst into weight-loss drug development.

Via The Motley Fool

Topics Intellectual Property

Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet ↗

September 26, 2025

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de

Via Benzinga

Topics Government World Trade

2 Top Passive Income Stocks to Buy Now ↗

September 26, 2025

These dividend stocks offer high yields and growth catalysts that could support payouts for decades.

Via The Motley Fool

Topics Bonds Economy Lawsuit

3 Absurdly Cheap Stocks You Can Buy for Less than $100 Right Now ↗

September 26, 2025

These stocks come with some uncertainty, but they have strong fundamentals and trade at low earnings multiples.

Via The Motley Fool

Topics World Trade

2 Oversold Stocks Primed to Rebound and 1 Facing Challenges

September 26, 2025

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling...

Via StockStory

< Previous 1 2

...

28 29 30 31 32 33 34 35 36

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.